Menu
GWAS Study

Genetics of blood lipids among ~300,000 multi-ethnic participants of the Million Veteran Program.

Klarin D, Damrauer SM, Cho K et al.

30275531 PubMed ID
GWAS Study Type
617303 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

KD
Klarin D
DS
Damrauer SM
CK
Cho K
SY
Sun YV
TT
Teslovich TM
HJ
Honerlaw J
GD
Gagnon DR
DS
DuVall SL
LJ
Li J
PG
Peloso GM
CM
Chaffin M
SA
Small AM
HJ
Huang J
TH
Tang H
LJ
Lynch JA
HY
Ho YL
LD
Liu DJ
EC
Emdin CA
LA
Li AH
HJ
Huffman JE
LJ
Lee JS
NP
Natarajan P
CR
Chowdhury R
SD
Saleheen D
VM
Vujkovic M
BA
Baras A
PS
Pyarajan S
DA
Di Angelantonio E
NB
Neale BM
NA
Naheed A
KA
Khera AV
DJ
Danesh J
CK
Chang KM
AG
Abecasis G
WC
Willer C
DF
Dewey FE
CD
Carey DJ
CJ
Concato J
GJ
Gaziano JM
OC
O'Donnell CJ
TP
Tsao PS
KS
Kathiresan S
RD
Rader DJ
WP
Wilson PWF
AT
Assimes TL
Chapter II

Abstract

Summary of the research findings

The Million Veteran Program (MVP) was established in 2011 as a national research initiative to determine how genetic variation influences the health of US military veterans. Here we genotyped 312,571 MVP participants using a custom biobank array and linked the genetic data to laboratory and clinical phenotypes extracted from electronic health records covering a median of 10.0 years of follow-up. Among 297,626 veterans with at least one blood lipid measurement, including 57,332 black and 24,743 Hispanic participants, we tested up to around 32 million variants for association with lipid levels and identified 118 novel genome-wide significant loci after meta-analysis with data from the Global Lipids Genetics Consortium (total n > 600,000). Through a focus on mutations predicted to result in a loss of gene function and a phenome-wide association study, we propose novel indications for pharmaceutical inhibitors targeting PCSK9 (abdominal aortic aneurysm), ANGPTL4 (type 2 diabetes) and PDE3B (triglycerides and coronary disease).

215,551 European ancestry individuals, 57,332 African American individuals, 24,743 Hispanic individuals

Chapter III

Study Statistics

Key metrics and study information

617303
Total Participants
GWAS
Study Type
Yes
Replicated
Up to 319,677 individuals
Replication Participants
African American or Afro-Caribbean, European, Hispanic or Latin American
Ancestry
U.S.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.